CannapharmarxCPMD +15.00% Receivables Turnover is 7.33 as of Mar. 2026. The stock has 6 warning signs investors should review. Among 946 Drug Manufacturers companies, Cannapharmarx ranks better than 74% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Cannapharmarx's Revenue for the
three
months ended in Mar. 2026 was $0.63 Mil. Cannapharmarx's average Accounts Receivable for the
three
months ended in Mar. 2026 was $0.09 Mil.
Hence, Cannapharmarx's Receivables Turnover for the
three
months ended in Mar. 2026 was 7.33.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Cannapharmarx Receivables Turnover Related Terms
Cannapharmarx Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Cannapharmarx's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CPMD vs NPHC, BSPK, UPC: Receivables Turnover Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Cannapharmarx's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cannapharmarx Receivables Turnover vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cannapharmarx's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Cannapharmarx's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannapharmarx (CPMD) has a Receivables Turnover of 7.33 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Cannapharmarx and its competitors. According to the industry distribution chart, Cannapharmarx ranks #246 out of 946 companies in the Drug Manufacturers industry, placing it in the top 26%.
Is Cannapharmarx's Receivables Turnover too high?
Cannapharmarx's current Receivables Turnover is 7.33. The Drug Manufacturers industry median Receivables Turnover is 5.07. Cannapharmarx's value of 7.33 is 44.6% above this industry median. Based on the distribution chart, Cannapharmarx ranks #246 out of 946 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does Cannapharmarx's Receivables Turnover compare to NPHC and BSPK?
According to the Drug Manufacturers industry distribution chart, Cannapharmarx ranks #246 out of 946 companies for Receivables Turnover. This puts Cannapharmarx in the upper half of its industry. The industry median Receivables Turnover is 5.07. Cannapharmarx's value of 7.33 is 44.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Drug Manufacturers company?
The median Receivables Turnover among Drug Manufacturers companies is 5.07, based on 946 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cannapharmarx's current Receivables Turnover of 7.33 is 44.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Cannapharmarx and its competitors. For the Drug Manufacturers industry, the median Receivables Turnover is 5.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannapharmarx's current Receivables Turnover is 7.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannapharmarx stock overvalued right now?
Cannapharmarx (CPMD) has a current Receivables Turnover of 7.33. The current Receivables Turnover is 7.33 and 44.6% above the Drug Manufacturers industry median of 5.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Cannapharmarx (CPMD), the current Receivables Turnover is 7.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cannapharmarx Inc specializes in the acquisition, development, and operation of cannabis cultivation facilities in Canada. The group evolved to focus on producing medical cannabis and craft products. The products of the company are Unique Genetics, Craft Products, and Medical Cannabis.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CPMD has been successfully added to your 